FDA Accepts Rise Therapeutics’ IND for Rheumatoid Arthritis Therapy Trial
https://reachmd.com/news/fda-accepts-rise-therapeutics-ind-for-rheumatoid-arthritis-therapy-trial/2462369/
R-2487 is intended for the treatment of rheumatoid arthritis. Credit: one photo/Shutterstock.com. …
Favorable Outcomes Reported for Novel Therapy Frexalimab in Reducing Disease Activity in Those with Relapsing Multiple Sclerosis
https://reachmd.com/news/favorable-outcomes-reported-for-novel-therapy-frexalimab-in-reducing-disease-activity-in-those-with-relapsing-multiple-sclerosis/2457314/
Frexalimab (SAR441344; Sanofi, Bridgewater, NJ), an investigational anti-CD40L monoclonal antibody, was shown to reduce disease activity in individuals with relapsing multiple sclerosis (RMS) according to study results published in The New England Journal of Medicine. Inhibition of CD40L with fre…
Benralizumab Proven Effective for Rare Vasculitis Treatment
https://reachmd.com/news/benralizumab-proven-effective-for-rare-vasculitis-treatment/2457297/
Researchers have shown that the drug benralizumab is as effective and safe as mepolizumab for inducing remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) according to a study published today in The New England Journal of Medicine. The results of the non-inferiority stu…
Rise Therapeutics Begins Rheumatoid Arthritis Therapy Trial
https://reachmd.com/news/rise-therapeutics-begins-rheumatoid-arthritis-therapy-trial/2457284/
The study will evaluate the pharmacodynamics, safety and clinical activity of R-2487 in rheumatoid arthr…
Dementia Risk Lowered by 6 Habits, Study Suggests
https://reachmd.com/news/dementia-risk-lowered-by-6-habits-study-suggests/2457140/
Adopting six simple lifestyle habits could significantly reduce your risk of dementia, scientists have said. Dementia affects over 5 million American adults over the age of 65, according to 2014 data from the U.S. Centers for Disease Control and Prevention. The condition comes in different forms—t…
Updated Guidelines Issued for Management of Anaphylaxis
https://reachmd.com/news/updated-guidelines-issued-for-management-of-anaphylaxis/2456704/
by Elana Gotkine In a practice parameter update published online Dec. 17 in the Annals of A…
Practicing Mindfulness and Managing Emotions Lead to Better Sleep, Says Study
https://reachmd.com/news/practicing-mindfulness-and-managing-emotions-lead-to-better-sleep-says-study/2467146/
Credit: Pixabay/CC0 Public Domain Mindfulness—focusing on the present moment—can improve sleep, reduce stress and improve overall health. A new University of South Florida-led study helps explain why.…
Study Demonstrates Sustained Reduction in Child Mortality Following Educational Interventions in Low-Resourced Countries
https://reachmd.com/news/study-demonstrates-sustained-reduction-in-child-mortality-following-educational-interventions-in-low-resourced-countries/2467027/
Mass General Brigham study authors Dr. Phoebe Yager, of Mass General for Children and Dr. Christopher Hartnick of Mass Eye and Ear (center) meet with Dr. Angel Ernesto Alvarado Rodríguez (far right), director of the Hospital N…
AJPH Study Reveals That COVID-19 Has Widened Racial Gaps in Pregnancy-Associated Deaths from Non-Obstetric Causes in the US
https://reachmd.com/news/ajph-study-reveals-that-covid-19-has-widened-racial-gaps-in-pregnancy-associated-deaths-from-non-obstetric-causes-in-the-us/2467012/
image: Re…
Genetic Analysis Reveals True Origin of Chronic Kidney Disease in Undiagnosed Patients
https://reachmd.com/news/genetic-analysis-reveals-true-origin-of-chronic-kidney-disease-in-undiagnosed-patients/2462590/
Tokyo, Japan – Chronic kidney disease (CKD) is extremely prevalent among adults, affecting over 800 million individuals worldwide. Many of these patients eventually require therapy to supplement or replace kidney functions, such as dialysis or kidney transplant. While most CKD cases originate fro…